About us



      The Radiopharmaceuticals Production and Research Centre (RPRC PET-UW) which is currently under construction at the Heavy Ion Laboratory (HIL), (part of the Warsaw University) will simultaneously serve as a research centre and a producer of radiopharmaceuticals mainly used in the technique of Positron Emission Tomography (PET). For the production of radioisotopes used in Positron Emission Tomography the medical cyclotron (GE-PETtrace) will be used, which accelerates protons up to the energy 16.5 MeV (it is also possible to accelerate the deuterons of energy 8.4 MeV). This cyclotron was installed in 2011 in the RPRC-PET-UW laboratory as a second cyclotron located at HIL. Since 1994, the heavy ion cyclotron of Kmax = 160 (with maximum particles energy up to 10 MeV / nucleon) works at HIL and it is the largest cyclotron in Poland. It is used by Polish and foreign teams for research in nuclear physics, atomic physics, materials research, solid state physics and biology. The experiments are also conducted with the objective to form 211At (the isotope used in the targeted alpha-therapy) in the reaction with 209Bi, using an internal beam of alpha particles.

     The centre has a complete facilities for the production of basic radiopharmaceutical fluorodeoxyglucose  18F-FDG, which includes: two 18F-FDG synthesizers, dual hot cell for synthesizers, two target systems for 18F productions, two dispensers and two hot cells for the dispensers. Target systems allow for the production of 18F with maximum activity of the isotope up to 3.5 Ci. It is also planned to produce other radiopharmaceuticals based on fluorine isotope 18F (18F choline, 18F Dopa) and other short-lived radioisotopes, such as 11C (11C -methionine),15O (H215O) or metallic radioisotopes.
   Currently, after the construction period years the Radiopharmaceuticals Production and Research Centre (RPRC-PET-UW) will become operational in March this year. The next stage of activity will be the registration of the basic radiopharmaceutical 18F-FDG and its commercialization, focusing on centers with PET scanners in Warsaw and not too far centers outside of Warsaw. At the end of the year in the research part of the center, in cooperation with other units of
Warsaw Consortium for PET Collaboration, long-term activity looking for new, innovative radiopharmaceuticals will begin.